Definition of molecular determinants of prostate cancer cell bone extravasation.

Abstract:

:Advanced prostate cancer commonly metastasizes to bone, but transit of malignant cells across the bone marrow endothelium (BMEC) remains a poorly understood step in metastasis. Prostate cancer cells roll on E-selectin(+) BMEC through E-selectin ligand-binding interactions under shear flow, and prostate cancer cells exhibit firm adhesion to BMEC via β1, β4, and αVβ3 integrins in static assays. However, whether these discrete prostate cancer cell-BMEC adhesive contacts culminate in cooperative, step-wise transendothelial migration into bone is not known. Here, we describe how metastatic prostate cancer cells breach BMEC monolayers in a step-wise fashion under physiologic hemodynamic flow. Prostate cancer cells tethered and rolled on BMEC and then firmly adhered to and traversed BMEC via sequential dependence on E-selectin ligands and β1 and αVβ3 integrins. Expression analysis in human metastatic prostate cancer tissue revealed that β1 was markedly upregulated compared with expression of other β subunits. Prostate cancer cell breaching was regulated by Rac1 and Rap1 GTPases and, notably, did not require exogenous chemokines as β1, αVβ3, Rac1, and Rap1 were constitutively active. In homing studies, prostate cancer cell trafficking to murine femurs was dependent on E-selectin ligand, β1 integrin, and Rac1. Moreover, eliminating E-selectin ligand-synthesizing α1,3 fucosyltransferases in transgenic adenoma of mouse prostate mice dramatically reduced prostate cancer incidence. These results unify the requirement for E-selectin ligands, α1,3 fucosyltransferases, β1 and αVβ3 integrins, and Rac/Rap1 GTPases in mediating prostate cancer cell homing and entry into bone and offer new insight into the role of α1,3 fucosylation in prostate cancer development.

journal_name

Cancer Res

journal_title

Cancer research

authors

Barthel SR,Hays DL,Yazawa EM,Opperman M,Walley KC,Nimrichter L,Burdick MM,Gillard BM,Moser MT,Pantel K,Foster BA,Pienta KJ,Dimitroff CJ

doi

10.1158/0008-5472.CAN-12-3264

subject

Has Abstract

pub_date

2013-01-15 00:00:00

pages

942-52

issue

2

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-12-3264

journal_volume

73

pub_type

杂志文章
  • Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13.

    abstract::We tested the influence of recombinant human interleukin (rhIL)-l3 and rhIL-4 on clonal growth of human breast cancer cell lines. rhIL-13 and rhIL-4 inhibited clonal growth of three of nine lines to approximately 50% of controls (ED50, 0.5 ng/ml). rhIl-13 reduced [3H]thymidine incorporation in all three cell lines: tw...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Serve H,Oelmann E,Herweg A,Oberberg D,Serve S,Reufi B,Mücke C,Minty A,Thiel E,Berdel WE

    更新日期:1996-08-01 00:00:00

  • Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth.

    abstract::Cyclooxygenase, involved in tumor growth and angiogenesis, converts arachidonic acid to prostaglandin (PG)H(2), which is immediately converted to bioactive prostanoids including PGE(2), PGD(2), thromboxane (TX)A(2) and PGI(2). To test the hypothesis that changes in the prostanoid profile alter cancer growth, we transd...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pradono P,Tazawa R,Maemondo M,Tanaka M,Usui K,Saijo Y,Hagiwara K,Nukiwa T

    更新日期:2002-01-01 00:00:00

  • A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

    abstract::We have previously reported that rodent tumor cell lines secrete a potent vascular permeability factor with a molecular weight of 34,000-42,000 (Senger et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Wash. DC), 219: 983-985, 1983). This tumor-secreted vas...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Senger DR,Perruzzi CA,Feder J,Dvorak HF

    更新日期:1986-11-01 00:00:00

  • Increase in radioresponse of murine tumors by treatment with indomethacin.

    abstract::Indomethacin, an inhibitor of prostaglandin (PG) synthesis, was investigated for its ability to increase radioresponse of two fibrosarcomas, FSA and NFSA, in C3Hf/Kam mice. In addition, the effect of indomethacin on radioresponse of hematopoietic tissue, jejunum, hair follicles, and tissues involved in the development...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Furuta Y,Hunter N,Barkley T Jr,Hall E,Milas L

    更新日期:1988-06-01 00:00:00

  • Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors.

    abstract::Medulloblastoma and central nervous system primitive neuroectodermal tumors (CNS-PNET) are aggressive, poorly differentiated brain tumors with limited effective therapies. Using Sleeping Beauty (SB) transposon mutagenesis, we identified novel genetic drivers of medulloblastoma and CNS-PNET. Cross-species gene expressi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-1261

    authors: Beckmann PJ,Larson JD,Larsson AT,Ostergaard JP,Wagner S,Rahrmann EP,Shamsan GA,Otto GM,Williams RL,Wang J,Lee C,Tschida BR,Das P,Dubuc AM,Moriarity BS,Picard D,Wu X,Rodriguez FJ,Rosemarie Q,Krebs RD,Molan AM,Dem

    更新日期:2019-03-01 00:00:00

  • Effect of high-fat diet on colon carcinogenesis in F344 rats treated with 1,2-dimethylhydrazine, methylazoxymethanol acetate, or methylnitrosourea.

    abstract::Male inbred F344 weanling rats were fed semipurified diets containing 20 or 5% beef fats. At 7 weeks of age, all animals except controls were given 1,2-dimethylhydrazine [DMH (150 mg/kg body weight s.c.; one dose)], methylazoxymethanol acetate [MAM acetate (35 mg/kg body weight i.p.; one dose)], or methylnitrosourea (...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Reddy BS,Watanabe K,Weisburger JH

    更新日期:1977-11-01 00:00:00

  • Effects of tumor promoters on the expression of a tumor-related multigenic set in human cells.

    abstract::We previously found that a minor subfraction of the human genomic DNA, corresponding to 2500-3000 nonrepetitive sequences of 3 kilobases each and designated as tumor-activated DNA (TaDNA) was transcriptionally active in Burkitt's lymphoma cells and almost inactive in normal lymphocytes growing in vitro following integ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hanania N,Castagna M,Shaool D,Zeliszewski D,Harel J

    更新日期:1985-12-01 00:00:00

  • Effects of inhibitors of polyamine biosynthesis on the growth and melanogenesis of murine melanoma cells.

    abstract::Both 2-difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase (EC 4.1.1.17), and methylglyoxal bis(guanylhydrazone) (MGBG), a competitive inhibitor of S-adenosylmethionine decarboxylase (EC 4.1.1.50), strikingly stimulated melanotic expression of murine Cloudman S91 melanoma cells. The st...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Käpyaho K,Sinervirta R,Jänne J

    更新日期:1985-04-01 00:00:00

  • Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas.

    abstract::Renal cell carcinoma is frequently infiltrated by cells of the immune system. This makes it important to understand interactions between cancer cells and immune cells so they can be manipulated to bring clinical benefit. Here, we analyze subsets and functions of T lymphocytes infiltrating renal cell tumors directly ex...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-0852

    authors: Attig S,Hennenlotter J,Pawelec G,Klein G,Koch SD,Pircher H,Feyerabend S,Wernet D,Stenzl A,Rammensee HG,Gouttefangeas C

    更新日期:2009-11-01 00:00:00

  • Targeting XRCC1 deficiency in breast cancer for personalized therapy.

    abstract::XRCC1 is a key component of DNA base excision repair, single strand break repair, and backup nonhomologous end-joining pathway. XRCC1 (X-ray repair cross-complementing gene 1) deficiency promotes genomic instability, increases cancer risk, and may have clinical application in breast cancer. We investigated XRCC1 expre...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-2929

    authors: Sultana R,Abdel-Fatah T,Abbotts R,Hawkes C,Albarakati N,Seedhouse C,Ball G,Chan S,Rakha EA,Ellis IO,Madhusudan S

    更新日期:2013-03-01 00:00:00

  • DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell lines.

    abstract::Mitomycin C (MMC), a known cytotoxic agent, requires cellular enzyme-mediated activation for effective antitumor activity. To study the bioreductive enzymes responsible for MMC activation in tumor cells, we examined the enzyme activities of DT-diaphorase (DTD) and NADPH:cytochrome P-450 reductase in 13 colon and gastr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mikami K,Naito M,Tomida A,Yamada M,Sirakusa T,Tsuruo T

    更新日期:1996-06-15 00:00:00

  • Adenine nucleotide transport in hepatoma mitochondria and its correlation with hepatoma growth rates and tumor size.

    abstract::Initial rates of [3H]adenosine diphosphate and [3H]adenosine triphosphate uptake were measured in mitochondria isolated from normal rat liver, regenerating liver, mouse hepatoma BW7756, and four Morris hepatomas (7777, 7800, 7794A, and 16) of varying degrees of malignancy. Results obtained demonstrate that (a) the app...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Barbour RL,Chan SH

    更新日期:1983-04-01 00:00:00

  • Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.

    abstract::FET cells, derived from an early-stage colon carcinoma, are nontumorigenic in athymic mice. Stable transfection of a dominant-negative transforming growth factor beta (TGFbeta) type II receptor (DNRII) into FET cells that express autocrine TGFbeta shows loss of TGFbeta signaling and increased tumorigenicity in vivo in...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5348

    authors: Wang J,Yang L,Yang J,Kuropatwinski K,Wang W,Liu XQ,Hauser J,Brattain MG

    更新日期:2008-05-01 00:00:00

  • Distinct mutational spectrum of the p53 gene in lung cancers from Chinese women in Hong Kong.

    abstract::Accumulating evidence suggests that the p53 gene is a good target for molecular epidemiological studies to search for risk factors in carcinogenic events. The lung cancer incidence for females in Hong Kong is unusually high, ranking among the highest in the world despite a low percentage with a history of smoking. To ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Takagi Y,Koo LC,Osada H,Ueda R,Kyaw K,Ma CC,Suyama M,Saji S,Takahashi T,Tominaga S

    更新日期:1995-11-15 00:00:00

  • Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cells.

    abstract::8-Chloro-cAMP (8-Cl-cAMP) is a novel agent that is able to inhibit the growth of a wide variety of cancer cell types in vitro and in vivo and, at doses devoid of toxicity, to achieve plasma concentrations in cancer patients in a range effective for cancer cell growth inhibition. In this study, we have demonstrated tha...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tortora G,di Isernia G,Sandomenico C,Bianco R,Pomatico G,Pepe S,Bianco AR,Ciardiello F

    更新日期:1997-11-15 00:00:00

  • Loss of the ceramide transfer protein augments EGF receptor signaling in breast cancer.

    abstract::Triple-negative breast cancers (TNBC) are especially refractory to treatment due to their negative hormone receptor and ErbB2/HER2 status. Therefore, the identification of cancer-associated deregulated signaling pathways is necessary to develop improved targeted therapies. Here, we show that expression of the ceramide...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-3069

    authors: Heering J,Weis N,Holeiter M,Neugart F,Staebler A,Fehm TN,Bischoff A,Schiller J,Duss S,Schmid S,Korte T,Herrmann A,Olayioye MA

    更新日期:2012-06-01 00:00:00

  • Identification of a novel gene, MASL1, within an amplicon at 8p23.1 detected in malignant fibrous histiocytomas by comparative genomic hybridization.

    abstract::We used comparative genomic hybridization to study malignant fibrous histiocytomas (MFHs) from 19 patients to detect changes in the copy number of DNA sequences, along entire chromosomes. Together with losses and gains in various chromosomal regions, distinct high-level amplifications were found at six loci (4q12-21, ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sakabe T,Shinomiya T,Mori T,Ariyama Y,Fukuda Y,Fujiwara T,Nakamura Y,Inazawa J

    更新日期:1999-02-01 00:00:00

  • Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.

    abstract::Silybin, a main component of the milk thistle of Silybum marianum, has been reported to possess anticancer activity. We investigated the effects of IdB 1016, a complex of silybin with phosphatidylcholine, on the development of mammary tumors appearing spontaneously in HER-2/neu transgenic mice. The mechanisms involved...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-2601

    authors: Provinciali M,Papalini F,Orlando F,Pierpaoli S,Donnini A,Morazzoni P,Riva A,Smorlesi A

    更新日期:2007-03-01 00:00:00

  • Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus.

    abstract::Human bronchial carcinoma is thought to develop through progressive stages from basal cell hyperplasia to squamous metaplasia, dysplasia, carcinoma in situ, and finally invasive cancer. In this study, we used tissue microdissection to examine loss of heterozygosity of chromosomes 3p21, 5q21, and 9p21 at each stage of ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Thiberville L,Payne P,Vielkinds J,LeRiche J,Horsman D,Nouvet G,Palcic B,Lam S

    更新日期:1995-11-15 00:00:00

  • Prostatic localization of spontaneous early invasive carcinoma in Lobund-Wistar rats.

    abstract::Animal models of human prostate cancer are very limited in number but are of obvious importance to develop. Dr. Morris Pollard (M. Pollard, J. Natl. Cancer Inst., 51: 1235-1241, 1973) has reported that Lobund-Wistar rats develop spontaneous metastatic prostatic cancer when they become old (approximately 25% incidence ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pugh TD,Chang C,Uemura H,Weindruch R

    更新日期:1994-11-15 00:00:00

  • Enhanced efflux of [3H]vinblastine from Chinese hamster ovary cells transfected with a full-length complementary DNA clone for the mdr1 gene.

    abstract::Multidrug-resistant Chinese hamster ovary cell clones stably transfected with, and overexpressing, the mouse mdr1 complementary DNA clone along with drug-sensitive Chinese hamster ovary control cells were characterized for their capacities to accumulate and retain [3H]vinblastine. Multidrug-resistant mdr1 transfectant...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hammond JR,Johnstone RM,Gros P

    更新日期:1989-07-15 00:00:00

  • RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma.

    abstract::Metabolic reprogramming is a hallmark of cancer that includes increased glucose uptake and accelerated aerobic glycolysis. This phenotype is required to fulfill anabolic demands associated with aberrant cell proliferation and is often mediated by oncogenic drivers such as activated BRAF. In this study, we show that th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-2215

    authors: Houles T,Gravel SP,Lavoie G,Shin S,Savall M,Méant A,Grondin B,Gaboury L,Yoon SO,St-Pierre J,Roux PP

    更新日期:2018-05-01 00:00:00

  • Inhibition by 2,6-dithiopurine and thiopurinol of binding of a benzo(a)pyrene diol epoxide to DNA in mouse epidermis and of the initiation phase of two-stage tumorigenesis.

    abstract::The chemotherapeutic agent 6-mercaptopurine was previously shown to inhibit the binding of 7r,8t-dihydroxy-9,10t-oxy-7,8,9,10-tetrahydro-benzo(a) pyrene (BPDE-I) to DNA in Chinese hamster ovary cells. Two compounds related to 6-mercaptopurine, 2,6-dithiopurine (DTP) and thiopurinol (TP), have been tested for inhibitio...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: MacLeod MC,Mann KL,Thai G,Conti CJ,Reiners JJ Jr

    更新日期:1991-09-15 00:00:00

  • Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin a

    abstract::The influences of pure human pluripotent colony-stimulating factor, highly purified pluripoietin alpha, pure recombinant human tumor necrosis factor alpha, pure recombinant human gamma-interferon, and natural prostaglandin E1 (PGE1) were evaluated on colony formation of multipotential and erythroid progenitor cells in...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lu L,Welte K,Gabrilove JL,Hangoc G,Bruno E,Hoffman R,Broxmeyer HE

    更新日期:1986-09-01 00:00:00

  • Binding analysis of the estrogen receptor to its specific DNA target site in human breast cancer.

    abstract::The estrogen receptor (ER) is a nuclear protein with a hormone- and a DNA-binding domain. We examined the DNA binding of ER in MCF-7 cells and 79 primary breast cancers by gel mobility shift assay using as a probe the estrogen response element (ERE). The mobility shift assay showed saturable, specific binding of ER to...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Foster BD,Cavener DR,Parl FF

    更新日期:1991-07-01 00:00:00

  • Tumor degeneration by human embryonic fibroblasts and its enhancement by interferon.

    abstract::KB cells from a human nasopharyngeal tumor were cocultivated with human embryonic fibroblasts (HF 8101 cells); 7 to 14 days after incubation, "spongy degeneration"-like changes developed in the target cell-growing area. These changes developed in other target cells [HeLa cells from human cervical cancer, human hepatom...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Imanishi J,Hoshino S,Matsuoka H,Uemura H,Imanishi T,Tanaka A,Nishino H,Kishida T

    更新日期:1983-09-01 00:00:00

  • Enhancement by 1 alpha,25-dihydroxyvitamin D3 of chemically induced transformation of BALB 3T3 cells without induction of ornithine decarboxylase or activation of protein kinase C1.

    abstract::We reported previously that 1 alpha,25-dihydroxyvitamin D3 [1 alpha,25(OH)2D3], a hormonally active form of vitamin D3, markedly enhanced methylcholanthrene-induced transformation of BALB 3T3 A31-1-1 cells. When the cells were treated with methylcholanthrene (1 microgram/ml) for 72 h and then with 1 alpha,25(OH)2D3 (5...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sasaki K,Chida K,Hashiba H,Kamata N,Abe E,Suda T,Kuroki T

    更新日期:1986-02-01 00:00:00

  • Antagonistic effect of butyrate on hexamethylene bisacetamide induced differentiation of murine erythroleukemia cells.

    abstract::Butyrate, at concentrations greater than 0.75 mM, induces hemoglobin accumulation in murine erythroleukemia cells (MELC). At concentrations below 0.75 mM, butyrate inhibits hemoglobin accumulation induced by hexamethylene bisacetamide (HMBA) as well as HMBA induced commitment to terminal cell division. The blocking of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Corin RE,Haspel HC,Peretz AM,Sonenberg M,Rifkind RA

    更新日期:1986-03-01 00:00:00

  • FoxM1 mediates resistance to herceptin and paclitaxel.

    abstract::Inherent and acquired therapeutic resistance in breast cancer remains a major clinical challenge. In human breast cancer samples, overexpression of the oncogenic transcription factor FoxM1 has been suggested to be a marker of poor prognosis. In this study, we report that FoxM1 overexpression confers resistance to the ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-0545

    authors: Carr JR,Park HJ,Wang Z,Kiefer MM,Raychaudhuri P

    更新日期:2010-06-15 00:00:00

  • DNA synthesis inpermeable mouse ascites sarcoma cells.

    abstract::DNA synthesis was studied in mouse ascites sarcoma cells using a permeable cell system. The sarcoma was induced by the Schmidt-Ruppin strain of Rous sarcoma virus. The cells were made permeable to nucleoside triphosphates by treatment with a hypotonic buffer containing 10 mM Tris Cl, 4 mM MgCl2, 1 mM EDTA, and 6 mM 2-...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Seki S,Oda T

    更新日期:1977-01-01 00:00:00